- Home
- AEI vs TLPH Comparison
AEI vs TLPH Comparison
Compare AEI & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEI
- TLPH
- Stock Information
- Founded
- AEI 2014
- TLPH 2005
- Country
- AEI United States
- TLPH United States
- Employees
- AEI N/A
- TLPH N/A
- Industry
- AEI Building operators
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- AEI Real Estate
- TLPH Health Care
- Exchange
- AEI Nasdaq
- TLPH Nasdaq
- Market Cap
- AEI 10.9M
- TLPH 10.6M
- IPO Year
- AEI N/A
- TLPH 2011
- Fundamental
- Price
- AEI $1.06
- TLPH $0.45
- Analyst Decision
- AEI
- TLPH Strong Buy
- Analyst Count
- AEI 0
- TLPH 1
- Target Price
- AEI N/A
- TLPH $6.00
- AVG Volume (30 Days)
- AEI 115.7K
- TLPH 42.9K
- Earning Date
- AEI 08-12-2025
- TLPH 08-13-2025
- Dividend Yield
- AEI N/A
- TLPH N/A
- EPS Growth
- AEI N/A
- TLPH N/A
- EPS
- AEI N/A
- TLPH N/A
- Revenue
- AEI $16,097,995.00
- TLPH $27,000.00
- Revenue This Year
- AEI N/A
- TLPH N/A
- Revenue Next Year
- AEI N/A
- TLPH $14,533.26
- P/E Ratio
- AEI N/A
- TLPH N/A
- Revenue Growth
- AEI N/A
- TLPH N/A
- 52 Week Low
- AEI $0.70
- TLPH $0.43
- 52 Week High
- AEI $2.61
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- AEI 56.70
- TLPH 45.62
- Support Level
- AEI $0.98
- TLPH $0.45
- Resistance Level
- AEI $1.30
- TLPH $0.52
- Average True Range (ATR)
- AEI 0.11
- TLPH 0.03
- MACD
- AEI 0.02
- TLPH -0.00
- Stochastic Oscillator
- AEI 52.43
- TLPH 35.33
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.